Eindhoven-based TIBO Energy, a company that manages network congestion, saves energy costs and reduces emissions with smart grid management, has secured €3M in a seed round of funding, to expand its team and venture into international markets. The investment was led by Amsterdam-based SET Ventures, with contributions from Speedinvest and TIBO Energy’s founding team members. Wij adviseerden SET Ventures bij deze investering.
Helin, an industrial edge intelligence platform, has closed a €3 million seed funding round led by FORWARD.one. The fresh capital infusion will primarily be allocated towards expanding Helin’s commercial and development teams, and further enhancing its state-of-the-art industrial edge intelligence SaaS platform. We advised FORWARD.one on this investment.
Amsterdam-based Farmless, a startup that aims to turn renewable energy and CO2 into carbon-negative food ingredients, has secured €4.8M in a seed round of funding. The investment was co-led by World Fund and Vorwerk Ventures. Farmless, which is crafting eco-friendly, functional proteins with a full amino acid profile, plans to use the proceeds for constructing a pilot protein brewery in Amsterdam. The funds will also support the development of Farmless’ fermentation platform and facilitate ongoing regulatory approval processes. We advised World Fund and Vorwerk Ventures on this investment.
Synerkine Pharma, a Dutch biopharmaceutical company creating innovative pain solutions, has closed an extension of its Series A financing led by Flerie with support from new investors, InnovationQuarter and Utrecht Health Seed Fund, and existing investor Thuja Capital. The equity financing is accompanied by a matching innovation credit from Rijksdienst voor Ondernemend (RVO) Nederland – the Netherlands Enterprise Agency. The total new proceeds of EUR 12.1 million will be used to accelerate the development of Synerkine Pharma’s lead asset SK-01, a therapeutically active cytokine fusion protein, into clinical studies in complex regional pain syndrome (CRPS), a severe chronic pain indication. We advised InnovationQuarter on this investment.
Dutch climate-tech IoT scale-up Sensorfact has raised a €25 million investment round from investors Blume Equity, FORWARD.one, Korys, and SET Ventures. Funds will fuel the expansion into new markets as Sensorfact optimises its current product suite. Sensorfact’s solution provides manufacturers the tools to monitor electricity, gas, water, and compressed air usage, optimise operations to make them more efficient and predict maintenance needs. We advised FORWARD.one, Korys and SET Ventures on this investment.
TU Delft spin-off Villari has secured a seed investment of €2.5 million by lead investor FORWARD.one and co-investors InnovationQuarter Capital and Delft Enterprises. Villari successfully developed innovative sensor technology to detect and monitor small fractures or “fatigue cracks” in steel structures. The monitoring of even the tiniest cracks is crucially important for steel assets that experience intense loads, like bridges with frequent traffic, or industrial cranes lifting heavy weights around the clock. Olym advised lead investor FORWARD.one on this investment.
YARD ENERGY has acquired a stake in Big Ass Battery, a Dutch high-tech scale-up that develops and builds energy storage systems. In addition, YARD ENERGY is providing growth financing. Big Ass Battery, based in Nuenen (NL), stands out for its innovative energy storage systems that are built entirely in-house. We advised YARD ENERGY, a venture capital investor in scale-ups playing a vital role in the energy transition.
Vitestro, developer of an autonomous blood drawing device, has completed a EUR 12 million Series A financing round. California-based Sonder Capital led the funding round alongside existing investors and new private investors with experience in the clinical laboratory and MedTech industry. The proceeds will be used to accelerate product development, prepare EU market authorization, and initiate production. Olym advised Sonder Capital on this investment.
3T, an Italian manufacturer of road and gravel bicycles, is bringing UTurn Investments on board to fund its international expansion plans. The investment also allows 3T to ramp up Italian production of strategic and innovative products, such as the signature carbon frames “RaceMax Italia”. The company will continue to be led by René Wiertz and Gérard Vroomen. We advised 3T in this transaction.
Enzyre, which is developing breakthrough ambulant diagnostic technology for blood coagulation testing, has raised €12 million in a Series A financing led by new investor, Oost NL, with participation from i&i Biotech Fund, Demcon Investment as technology partner and existing investors, Takeda Ventures and Novalis Biotech. Part of the funding is an Innovation Credit from the Dutch Government. The proceeds from the financing will enable Enzyre to further develop its unique diagnostic technology platform, EnzyPad, which will enable hemophilia patients to determine and monitor their coagulation status from home in real-time. Olym advised Enzyre in this funding round.